Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine

E Karbassi, A Fenix, S Marchiano, N Muraoka… - Nature Reviews …, 2020 - nature.com
Our knowledge of pluripotent stem cell (PSC) biology has advanced to the point where we
now can generate most cells of the human body in the laboratory. PSC-derived …

Human engineered heart tissue models for disease modeling and drug discovery

H Tani, S Tohyama - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
The emergence of human induced pluripotent stem cells (hiPSCs) and efficient
differentiation of hiPSC-derived cardiomyocytes (hiPSC-CMs) induced from diseased …

Gene editing to prevent ventricular arrhythmias associated with cardiomyocyte cell therapy

S Marchiano, K Nakamura, H Reinecke, L Neidig… - Cell Stem Cell, 2023 - cell.com
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) offer a promising cell-
based therapy for myocardial infarction. However, the presence of transitory ventricular …

3D co-culture of hiPSC-derived cardiomyocytes with cardiac fibroblasts improves tissue-like features of cardiac spheroids

P Beauchamp, CB Jackson, LC Ozhathil… - Frontiers in molecular …, 2020 - frontiersin.org
Purpose: Both cardiomyocytes and cardiac fibroblasts (CF) play essential roles in cardiac
development, function, and remodeling. Properties of 3D co-cultures are incompletely …

Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes

F Seibertz, H Sutanto, R Dülk, JRD Pronto… - Basic Research in …, 2023 - Springer
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly
used for personalised medicine and preclinical cardiotoxicity testing. Reports on hiPSC-CM …

Human myofibroblasts increase the arrhythmogenic potential of human induced pluripotent stem cell-derived cardiomyocytes

RD Johnson, M Lei, JH McVey, P Camelliti - Cellular and Molecular Life …, 2023 - Springer
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have the
potential to remuscularize infarcted hearts but their arrhythmogenicity remains an obstacle to …

Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and …

AJS Ribeiro, BD Guth, M Engwall, S Eldridge… - Frontiers in …, 2019 - frontiersin.org
Contractility of the myocardium engines the pumping function of the heart and is enabled by
the collective contractile activity of its muscle cells: cardiomyocytes. The effects of drugs on …

Improved computational identification of drug response using optical measurements of human stem cell derived cardiomyocytes in microphysiological systems

KH Jæger, V Charwat, B Charrez, H Finsberg… - Frontiers in …, 2020 - frontiersin.org
Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) hold great
potential for drug screening applications. However, their usefulness is limited by the relative …

Efficient differentiation of human pluripotent stem cells into cardiomyocytes on cell sorting thermoresponsive surface

TC Sung, HC Su, QD Ling, SS Kumar, Y Chang… - Biomaterials, 2020 - Elsevier
The current differentiation process of human pluripotent stem cells (hPSCs) into
cardiomyocytes to enhance the purity of hPSC-derived cardiomyocytes requires some …

Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs

R Shi, M Reichardt, DJ Fiegle, LK Küpfer… - Cardiovascular …, 2023 - academic.oup.com
Aims Cardiotoxicity is one major reason why drugs do not enter or are withdrawn from the
market. Thus, approaches are required to predict cardiotoxicity with high specificity and …